The media center provides current and archived information about Millennium: The Takeda Oncology Company. This includes information about our company, products, pipeline and relevant diseases.
divider
Media Contacts
Karen Gobler
Karen Gobler

Phone:  617-444-1392
Fax:  617-374-7788
Email:  pr@mlnm.com
 
Manisha Pai
Manisha Pai

Phone:  617-551-7877
Fax:  617-374-7788
Email:  pr@mlnm.com
divider
News Releases »
5/31/2009
In Clinical Trials VELCADE® (bortezomib) for Injection as a Foundation of Therapy Continues to Deliver Significant Response Rates in Previously Untreated Multiple Myeloma Patients More
5/31/2009
The Addition of VELCADE® (bortezomib) for Injection to New and Standard Combinations Delivers Promising Results in Patients with Non-Hodgkin’s Lymphoma More
divider
Background Information
Boston Globe's 2008 Best Places to Work
best place to work
Yasuchika Hasegawa and Deborah Dunsire hold the award presented to Millennium.
 
Management Team
management team
Our senior leaders invest their time and skill setting our focus and prioritizing our resources to deliver progress against cancer.
 
Our Parent Company
Information about our parent company, Takeda Pharmaceutical Company Limited, is available through our media contacts or by contacting Takeda directly.
 
divider
© 2009 Millennium Pharmaceuticals, Inc.
A wholly-owned subsidiary of Takeda Pharmaceutical Company Limited
Update Notice | Usage Terms | Privacy Policy